Sanofi’s $40 Million Investment in Vigil Neuroscience

Leila Ahmed
Tagged:

Ropes & Gray advised Sanofi on the transaction, and Goodwin Procter advised Vigil Neuroscience. Sanofi (Nasdaq: SNY) has made a $40 million strategic investment in Vigil…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now